Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo.

Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo.

Item
http://www.wikidata.org/entity/Q44927078
β1-adrenergic receptor antagonists signal via PDE4 translocationModeling the effects of β1-adrenergic receptor blockers and polymorphisms on cardiac myocyte Ca2+ handling.MARCH2 promotes endocytosis and lysosomal sorting of carvedilol-bound β(2)-adrenergic receptorsBeta-blocker therapy of heart failure: an update.Carvedilol: a third-generation β-blocker should be a first-choice β-blocker.Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic EmPDE3, but not PDE4, reduces β₁ - and β₂-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients.Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).Erectile dysfunction may improve by blood pressure control in patients with high-risk hypertension.Functional effects of β₁-adrenoceptor polymorphisms on the hemodynamic response to dobutamine with and without β-blocker administration.Effect of carvedilol and metoprolol on the mode of death in patients with heart failure.Current concepts of pharmacotherapy in hypertension. Carvedilol: new considerations for its use in the diabetic patient with hypertension.A frequent gene polymorphism affecting the heart-rate response to carvedilol.Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial.Differential effects of carvedilol and metoprolol succinate on plasma norepinephrine release and peak exercise heart rate in subjects with chronic heart failure.
P2860

Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo.

Item
http://www.wikidata.org/entity/Q44927078
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Carvedilol but not metoprolol ...... imination from plasma in vivo.
@en
Carvedilol but not metoprolol ...... imination from plasma in vivo.
@nl
type
label
Carvedilol but not metoprolol ...... imination from plasma in vivo.
@en
Carvedilol but not metoprolol ...... imination from plasma in vivo.
@nl
prefLabel
Carvedilol but not metoprolol ...... imination from plasma in vivo.
@en
Carvedilol but not metoprolol ...... imination from plasma in vivo.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Carvedilol but not metoprolol ...... imination from plasma in vivo.
@en
P2093
P304
P31
P356
10.1161/01.CIR.0000130849.08704.24
P407
P433
P478
P577
P698